CorMedix Inc - Company & Market Research Reports

CorMedix is a commercial-stage pharmaceutical company focused on the treatment of infectious, inflammatory, and other serious diseases. The company markets Neutrolin, a catheter lock solution for the prevention of catheter related bloodstream infections. Neutrolin is approved as a CE Marked medical device in Europe where it was shown to reduce catheter-related bloodstream infections by 96% and thrombosis by 96.7%. Founded in 2006, it is based in Bridgewater, New Jersey.

Neuroblastoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 543 Pages
From
Neuroblastoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2017

  • Drug Pipelines
  • 506 Pages
From
From
From
Osteosarcoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 498 Pages
From
Osteosarcoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 421 Pages
From
Osteosarcoma - Pipeline Insight, 2018 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
From
Cormedix Incorporation - Product Thumbnail Image

Cormedix Incorporation

  • Company Profile
  • 75 Pages
Loading Indicator
adroll